NCT02423031

Brief Summary

Background: \- Medical problems and treatments can cause stress in some people. Researchers want to learn more about how to measure distress in young people with medical illnesses. A screening tool called Checking In will be developed in order to help researchers find ways to identify concerns and stresses common to this group. Objective: \- To create a screening tool that will help health care providers identify psychological and social distress in young people with serious illnesses. Eligibility: \- Outpatient youth ages 8 21 who are enrolled on a research protocol at the NIH at the time of the study. Design:

  • Phase 1 participants will complete a paper-and-pencil version of Checking In. It asks about mood, pain, fatigue, peer relationships, and sleep. During this phase, participants will be asked about the wording of the questions in Checking In. They will also talk about what they thought of the questions and if they understood them.
  • Phase 2 will not involve participant enrollment. During this phase the researchers will be working with technologists to develop the software for an electronic version of Checking In.
  • Phase 3 participants will complete an electronic version of Checking In. Researchers will ask questions about the ease or difficulty of using an electronic screen.
  • Phase 4 participants and one of their caregivers will complete an electronic version of Checking In. They will also complete other questionnaires related to mood, pain fatigue, peer relationships and sleep. They will be asked their thoughts about using Checking In. On the same day, their NIH doctor will get summary data about their questionnaire answers. The doctor will also provide feedback about the summary form.
  • Researchers will compare data from Checking In with data from the other questionnaires.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
178

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2015

Longer than P75 for all trials

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 14, 2015

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

April 18, 2015

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 22, 2015

Completed
6.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 10, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 10, 2021

Completed
Last Updated

May 31, 2025

Status Verified

May 1, 2025

Enrollment Period

6.6 years

First QC Date

April 18, 2015

Last Update Submit

May 30, 2025

Conditions

Keywords

Physiological MeasuresEmotional ContextPediatricDistress ScreeningNatural History

Outcome Measures

Primary Outcomes (1)

  • Positive score on depression, anxiety, pain and fatigue measures

    Positive score on depression, anxiety, pain and fatigue measures

    Ongoing

Study Arms (2)

Caregivers

caregivers of pediatric patients with cancer and other serious illnesses

pediatric patients

pediatric patients with cancer and other serious illnesses

Eligibility Criteria

Age8 Years - 21 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

pediatric cancer patients

You may qualify if:

  • Age 8 to 21 years.
  • Must be enrolled in a research protocol at the NIH or receiving cancer treatment or follow-up care at Johns Hopkins, Children s Hospital Colorado, or Levine Children s Hospital and be an outpatient at time of study. The treatment protocol PI will be contacted before a patient is approached to ensure that the patient is appropriate for enrollment into this protocol.
  • Must have a parent/guardian available to complete the study measures.
  • Patients and caregiver must be be able to read in English and write in English (as all instruments have not been validated in other languages)
  • \<TAB\>

You may not qualify if:

  • Patients can be excluded from this study if there is a presence of psychotic symptoms or cognitive impairment, which in the judgment of the Principal or Associate Investigator, or consulting psychiatrist would compromise the patient s ability to accurately complete the measures.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Children's Hospital Colorado

Aurora, Colorado, 80045, United States

Location

Johns Hopkins University

Baltimore, Maryland, 21218, United States

Location

National Institutes of Health Clinical Center

Bethesda, Maryland, 20892, United States

Location

Carolinas Medical Center Levine Children's Hospital

Charlotte, North Carolina, 28203, United States

Location

Related Links

MeSH Terms

Conditions

Neoplasms

Study Officials

  • Maryland Pao, M.D.

    National Institute of Mental Health (NIMH)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
NIH
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 18, 2015

First Posted

April 22, 2015

Study Start

April 14, 2015

Primary Completion

November 10, 2021

Study Completion

November 10, 2021

Last Updated

May 31, 2025

Record last verified: 2025-05

Locations